FindTrial
Sign In

Efficacy of Helicobacter pylori eradication in chronic urticaria

A Non blinded Randomized Controlled Trial to assess the efficacy of Helicobacter pylori eradication in patients with chronic urticaria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052624
Enrollment
110
Registered
2023-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

Intervention1: Eradication kit for Helicobacter pylori: Half of the patients who test positive for helicobacter pylori will be given tinidazole 500 mg BD + clarithromycin 250 mg BD + lansoprazole 30 m

Sponsors

Department of Dermatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically diagnosed cases of chronic urticaria with a positive result in the Helicobacter pylori stool antigen test

Exclusion criteria

Exclusion criteria: Patients taking proton pump inhibitors/ H2 blockers/ antibiotics/ oral steroids in last 2 weeks

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Helicobacter pylori eradication in the management of chronic urticariaTimepoint: Follow up at 3 months and 6 months—

Secondary

MeasureTime frame
Successful eradication of Helicobacter pyloriTimepoint: After completion of eradication therapy for 14 days—

Countries

India

Contacts

Public ContactDr Ritika Khanna

Institute of Medical Sciences

drsatyendraderma@gmail.com9198120582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026